ALBANY, New York, July 22, 2014 /PRNewswire/ -- AMRI (NASDAQ:
AMRI) today announced it will issue second quarter financial
results before the opening of the market on Tuesday, August 5, 2014. Following the
release of its results, the company will host a conference call and
simultaneous audio webcast at 10:00 a.m.
ET.
The conference call can be accessed by dialing 888-505-4375
(domestic calls) or 719-325-2323 (international calls) at
9:50 a.m. ET and entering passcode
9752010. The audio webcast will be available live via the
Internet and can be accessed on the company's website at
www.amriglobal.com.
Replay of the conference call can be accessed by dialing
888-203-1112 (domestic calls) or 719-457-0820 (international calls)
and entering passcode 9752010 from Tuesday,
August 5, 2014 at 2:00 p.m. ET
to Wednesday, August 6, 2014 at
2:00 p.m. ET. Replay of the
audio webcast can also be accessed for up to 90 days after the call
via the investor area of the company's website at
www.amriglobal.com/investor_relations/.
About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract
research and manufacturing organization that has been working with
the Life Sciences industry to improve patient outcomes and the
quality of life for more than two decades. With locations in
North America, Europe and Asia, our key business segments include Large
Scale Manufacturing (LSM) and Discovery and Development Solutions
(DDS). The LSM segment includes Active Pharmaceutical Ingredients
(API) and Drug Product Manufacturing, which supports the commercial
cGMP manufacturing of complex APIs, starting materials, clinical
formulation development and aseptic fill and finish. Our DDS
segment provides comprehensive services from hit identification to
IND, including expertise with diverse chemistry, library design and
synthesis, in vitro biology and pharmacology, drug
metabolism and pharmacokinetics, as well as natural products. For
more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).